FDA Inspection 1312808 — Catalent Massachusetts, LLC

Catalent Massachusetts, LLC — FEI 3011696115

The FDA completed an inspection of Catalent Massachusetts, LLC on April 7, 2026 in Chelsea, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 7, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chelsea, MA (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented